Comparison of Treatment Tolerance and Outcomes in Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy in a Prospective Randomized Trial or With Standard Treatment

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 1, 2008, Pages 118-125

  Torres, Mylin A ^a   Jhingran, Anuja ^a   Thames Jr , Howard D ^a   Levenback, Charles F ^a   Bodurka, Diane C ^a   Ramondetta, Lois M ^a   Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cervical cancer; Compliance; Concurrent chemoradiotherapy; Outcome; Treatment tolerance

Indexed keywords

CHEMOTHERAPY; MEDICAL PROBLEMS; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

CERVICAL CANCER; CONCURRENT CHEMORADIOTHERAPY; TREATMENT TOLERANCE;

ONCOLOGY;

CISPLATIN; FLUOROURACIL;

ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TINNITUS; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; LEUKOPENIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPENIA; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 37049003970     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.028     Document Type: Article

References (10)

1. Eifel P.J., Moughan J., Erickson B., et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: A patterns of care study. Int J Radiat Oncol Biol Phys 60 (2004) 1144-1153
2. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
3. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
4. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
5. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
6. Wong L.C., Ngan H.Y., Cheung A.N., et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 17 (1999) 2055-2060
7. Jhingran A. Acute toxicity of chemoradiation for cervical cancer. [Abstract]. Cancer J 10 Suppl. 1 (2004) 40
8. Abu-Rustum N.R., Lee S., Correa A., et al. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol 81 (2001) 88-91
9. Serkies K., and Jassem J. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: A report on patient compliance and acute toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 814-821
10. Cetina L., Rivera L., Hinojosa J., et al. Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin: Five-year results. BMC Womens Health 6 (2006) 3